Progressive MS
Showing 1 - 25 of 7,455
Multiple Sclerosis, Chronic Progressive Trial in United States (NurOwn (MSC-NTF cells))
Completed
- Multiple Sclerosis, Chronic Progressive
- NurOwn (MSC-NTF cells)
-
Los Angeles, California
- +3 more
Oct 20, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab
Withdrawn
- Primary Progressive Multiple Sclerosis
- +2 more
- Intranasal Foralumab Solution
- Placebo
- (no location specified)
Feb 14, 2022
Gray Matter Demyelination in Primary Progressive MS at 7T
Recruiting
- Primary Progressive Multiple Sclerosis
-
Hvidovre, DenmarkDanish Research Centre for Magnetic Resonance
Jun 5, 2022
Multiple Sclerosis (MS) Patients
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- (no location specified)
Dec 15, 2022
Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Metformin Hydrochloride 850 mg Oral Tablet
- Placebo
-
Brugge, Belgium
- +4 more
May 30, 2023
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis
- Cladribine Subcutaneous Injection
- 0.9% Chloride Injection Sodium
-
Warsaw, Mazowieckie, PolandInstitute of Psychiatry and Neurology
Jul 26, 2023
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston
Recruiting
- Primary Progressive Multiple Sclerosis
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2021
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive
Completed
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- 18F-DPA-714 and 18F-FDG
-
Paris, France
- +1 more
Sep 14, 2022
Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco
Not yet recruiting
- Multiple Sclerosis (MS)
- +6 more
- Clemastine Fumarate
- Placebo
-
San Francisco, CaliforniaSandler Neurosciences Building, Neurological Clinical Research U
Jan 23, 2023
Multiple Sclerosis (MS) Registries
Active, not recruiting
- Progressive Multifocal Leukoencephalopathy
- Tysabri
-
Cambridge, MassachusettsResearch Site
Mar 21, 2022
Progressive Multiple Sclerosis, Fatigue Trial in San Francisco (N-acetyl cysteine, Placebo)
Completed
- Progressive Multiple Sclerosis
- Fatigue
- N-acetyl cysteine
- Placebo
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 6, 2022
Multiple Sclerosis Trial in Cardiff (LEAP-MS)
Completed
- Multiple Sclerosis
- LEAP-MS
-
Cardiff, United KingdomCentre for Trials Research
Jul 1, 2021
Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,
Completed
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Primary Progressive
- Training groupe
- +3 more
-
Kaposvár, Somogy, HungarySomogy Megyei Kaposi Mór Oktató Kórház
Mar 24, 2022
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial
Active, not recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- ACTH
- Placebo
-
Minneapolis, Minnesota
- +2 more
Mar 29, 2022
Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)
Active, not recruiting
- Multiple Sclerosis
- Lipoic acid
- Placebo
-
Birmingham, Alabama
- +10 more
Jan 31, 2023
Multiple Sclerosis Trial in New York (Active RS-tDCS +At-Home Manual Dexterity Training, Sham RS-tDCS +At-Home Manual Dexterity
Completed
- Multiple Sclerosis
- Active RS-tDCS +At-Home Manual Dexterity Training
- +2 more
-
New York, New YorkNew York University School of Medicine
Feb 11, 2022
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection, Intrathecal saline injection)
Active, not recruiting
- Multiple Sclerosis
- Intrathecal MSC-NP injection
- Intrathecal saline injection
-
New York, New YorkTisch MS Research Center of New York
Oct 25, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Multiple Sclerosis Trial in New York (Intrathecal MSC-NP injection)
Temporarily not available
- Multiple Sclerosis
- Intrathecal MSC-NP injection
-
New York, New YorkTisch MS Research Center of New York
Feb 7, 2022
MS-ResearchBiomarkerS
Recruiting
- Multiple Sclerosis
- +10 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 26, 2022
Automated EDSS Score Calculation by Smartphone Application
Completed
- MS CHRONIC PROGRESSIVE
- neurological exam
-
Nice, FranceNice University Hospital
Mar 17, 2022
Imaging Interplay Between Axonal Damage and Repair in Multiple
Recruiting
- Multiple Sclerosis (MS)
- +3 more
- MRI
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Neurology
Dec 15, 2021
Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)
Completed
- Multiple Sclerosis, Primary Progressive
-
Calgary, Alberta, CanadaMS Clinic Foothills Medical Centre
Jul 28, 2021
MS - a Prospective Cohort Study
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- PASS-MS
-
Berlin, GermanyExperimental and Clinical Research Center, Studienambulanz Neuro
Aug 9, 2021